Log In
Print
BCIQ
Print
Print this Print this
 

AVL-292, CC-292

  Manage Alerts
Collapse Summary General Information
Company Celgene Corp.
DescriptionCovalent small molecule Bruton's tyrosine kinase (Btk) inhibitor
Molecular Target Bruton's tyrosine kinase (Btk)
Mechanism of ActionBruton's tyrosine kinase (Btk) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today